Last update 04 Apr 2025

Iopromide

Overview

Basic Info

Drug Type
Contrast agent, Small molecule drug
Synonyms
Iopromide (JAN/USP/INN), N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylisophthalamide, 碘普胺
+ [7]
Action
antagonists, enhancers
Mechanism
M1 receptor antagonists(Muscarinic acetylcholine receptor M1 antagonists), M3 receptor antagonists(Muscarinic acetylcholine receptor M3 antagonists), Radiography enhancers
Inactive Indication-
Originator Organization-
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
Australia (12 Sep 1991),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC18H24I3N3O8
InChIKeyDGAIEPBNLOQYER-UHFFFAOYSA-N
CAS Registry73334-07-3

External Link

KEGGWikiATCDrug Bank
D01893Iopromide

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Breast Diseases
United States
25 May 2023
Aortic Diseases
United States
10 May 1995
Cardiovascular Diseases
United States
10 May 1995
Cerebrovascular Disorders
United States
10 May 1995
Coronary Disease
United States
10 May 1995
Peripheral Arterial Disease
United States
10 May 1995
Urethral Diseases
United States
10 May 1995
Contrast agents
Australia
12 Sep 1991
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
132,850
(Children (<18 years))
hoisaqlqxs(cmlbiigyqq) = sjpsnvlejf dqpqguwvpz (ixfgxgnqyb )
-
01 Dec 2021
(Elderly (≥65 years))
hoisaqlqxs(cmlbiigyqq) = eggdesvlyr dqpqguwvpz (ixfgxgnqyb )
Phase 3
435
(Iopromide 370 mg I/mL)
qikzlhgksm = nfljjtocly sijfyszxwt (jtuldjhurz, wqcoxcutbt - npykzogpwv)
-
20 Jul 2009
(Iopromide 300 mg I/mL)
qikzlhgksm = hcxupdykiq sijfyszxwt (jtuldjhurz, gjkphdasly - eiqwvsdrof)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free